Detail akcie MediPharm Labs Rg online

Business Summary: MediPharm Labs Corp. is a Canada-based pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. It develops, formulates, processes, packages and distributes cannabis and advanced cannabinoid-based products to domestic and international medical markets. The Company cultivates and processes cannabis to sell as dried flower, pre-roll and other cannabis products for adult use, medical, and international markets. The Company also provides GMP flower sourcing, packaging, and distribution services for select international clients. Its wholly owned subsidiary Harvest Medicine Inc. operates medical clinics in Canada that provide medical cannabis patients with physician consultations for medical cannabis education and prescriptions. Its international subsidiaries include Beacon Medical Germany GmbH and Beacon Medical Australia Pty Ltd.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Medipharm Labs Corp revenues increased 14% to C$34.1M. Net loss decreased 30% to C$6.3M. Revenues reflect Products transferred at a point in time segment increase of 20% to C$32.9M, Germany segment increase from C$4.7M to C$9.5M, Australia segment increase of 28% to C$8.2M. Lower net loss reflects FV Adjustments on Biological Assets increase from C$672K to C$1.4M (income).